StockNews.com upgraded shares of 22nd Century Group (NASDAQ:XXII – Free Report) to a sell rating in a research note published on Thursday morning. 22nd Century Group Price Performance Shares of NASDAQ:XXII opened at $1.24 on Thursday. 22nd Century Group has a twelve month low of $1.23 and a twelve month high of $164.40. The stock […]
StockNews.com upgraded shares of 22nd Century Group (NASDAQ:XXII – Free Report) to a sell rating in a research report report published on Friday morning. 22nd Century Group Price Performance Shares of XXII opened at $1.40 on Friday. The company has a quick ratio of 0.43, a current ratio of 0.54 and a debt-to-equity ratio of […]
Heritage Wealth Advisors boosted its position in shares of 22nd Century Group, Inc. (NASDAQ:XXII – Free Report) by 102.0% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 256,195 shares of the biotechnology company’s stock after acquiring an additional 129,372 shares during the quarter. Heritage Wealth Advisors’ holdings in 22nd Century Group were worth […]
22nd Century Group (NASDAQ:XXII – Get Free Report) is scheduled to be releasing its earnings data on Monday, November 6th. 22nd Century Group (NASDAQ:XXII – Get Free Report) last released its quarterly earnings data on Monday, August 14th. The biotechnology company reported ($1.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.05) […]
22nd Century Group, Inc. (NASDAQ:XXII – Get Free Report) saw a large drop in short interest during the month of August. As of August 15th, there was short interest totalling 1,260,000 shares, a drop of 40.8% from the July 31st total of 2,130,000 shares. Based on an average daily trading volume, of 1,310,000 shares, the […]